_id
691855693c536f8df231792d
Ticker
0GZK.LSE
Name
Ion Beam Applications S.A.
Exchange
LSE
Address
3, Chemin du Cyclotron, Louvain-la-Neuve, Belgium, 1348
Country
UK
Sector
Industry
Currency
EUR
Website
https://www.iba-worldwide.com
Description
Ion Beam Applications SA designs, produces, and markets solutions for cancer diagnosis and treatments in Belgium, the United States, and internationally. It operates through Proton Therapy and Other Accelerators; and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production of positron emission tomography or SPECT radioisotopes, as well as a line of industrial accelerators for sterilization and ionization. The Dosimetry segment provides solutions and services that enhances efficiency and minimizes errors in radiation therapy and medical imaging quality assurance and calibration procedures. The company has strategic research and development partnership with SCK CEN, a Belgian nuclear research center focusing on the development of Actinium-225, a radioactive isotope for the treatment of cancer. It also develops ConformalFLASH, a novel technique using the proton Bragg peak. Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium.
Last Close
13.35
Volume
3359
Current Price
13.22
Change
-0.08
Last Updated
2026-01-08T13:47:03.181Z
Image
https://logo.clearbit.com/www.iba-worldwide.com
Ipo Date
-
Market Cap
495901792
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2023-06-30
Revenue
-
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
-
Operating Income
-
Interest Expense
-
Pretax Income
-
Net Income
-
Eps
-
Dividends Per Share
-
Shares Outstanding
29316900
Income Tax Expense
2303500
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
-
Cash
-
Short Term Investments
-
Receivables
188557000
Inventories
189566000
Total Current Assets
483003000
Property Plant Equipment
47313000
Total Assets
-
Payables
65723000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
478044000
Equity
-
Bs_currency_symbol
EUR
Depreciation
2712000
Change In Working Capital
-
Cash From Operations
-21869000
Capital Expenditures
1265500
Cash From Investing
-3407500
Cash From Financing
-1605000
Net Change In Cash
-26235500
Cf_currency_symbol
EUR
PE
1.3163
PB
-
ROE
-
ROA
-
FCF
-23134500
Fcf Percent
-
Piotroski FScore
0
Health Score
45
Deep Value Investing Score
2.5
Defensive Investing Score
5
Dividend Investing Score
1.5
Economic Moat Investing Score
1
Garp Investing Score
0
Growth Investing Score
0
Momentum Investing Score
2
Net Net Investing Score
0
Quality Investing Score
0
Value Investing Score
4
Quarters > 0 > quarter
2023-06-30
Quarters > 0 > income Statement > revenue
-
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
-
Quarters > 0 > income Statement > operating Income
-
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-
Quarters > 0 > income Statement > net Income
-
Quarters > 0 > income Statement > eps
-
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
-
Quarters > 0 > income Statement > income Tax Expense
2303500
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
EUR
Quarters > 0 > balance Sheet > cash
-
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
188557000
Quarters > 0 > balance Sheet > inventories
189566000
Quarters > 0 > balance Sheet > total Current Assets
483003000
Quarters > 0 > balance Sheet > property Plant Equipment
47313000
Quarters > 0 > balance Sheet > total Assets
-
Quarters > 0 > balance Sheet > payables
65723000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
478044000
Quarters > 0 > balance Sheet > equity
-
Quarters > 0 > balance Sheet > currency_symbol
EUR
Quarters > 0 > cash Flow > net Income
-13631500
Quarters > 0 > cash Flow > depreciation
2712000
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-21869000
Quarters > 0 > cash Flow > capital Expenditures
1265500
Quarters > 0 > cash Flow > cash From Investing
-3407500
Quarters > 0 > cash Flow > cash From Financing
-1605000
Quarters > 0 > cash Flow > net Change In Cash
-26235500
Quarters > 0 > cash Flow > currency_symbol
EUR
Quarters > 0 > ratios > PE
-
Quarters > 0 > ratios > PB
-
Quarters > 0 > ratios > ROE
-
Quarters > 0 > ratios > ROA
-
Quarters > 0 > ratios > FCF
-23134500
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
45
Quarters > 1 > quarter
2023-03-31
Quarters > 1 > income Statement > revenue
-
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
-
Quarters > 1 > income Statement > operating Income
-
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-
Quarters > 1 > income Statement > net Income
-
Quarters > 1 > income Statement > eps
-
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
-
Quarters > 1 > income Statement > income Tax Expense
2303500
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
EUR
Quarters > 1 > balance Sheet > cash
-
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
188557000
Quarters > 1 > balance Sheet > inventories
189566000
Quarters > 1 > balance Sheet > total Current Assets
483003000
Quarters > 1 > balance Sheet > property Plant Equipment
47313000
Quarters > 1 > balance Sheet > total Assets
-
Quarters > 1 > balance Sheet > payables
65723000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
478044000
Quarters > 1 > balance Sheet > equity
-
Quarters > 1 > balance Sheet > currency_symbol
EUR
Quarters > 1 > cash Flow > net Income
-13631500
Quarters > 1 > cash Flow > depreciation
2712000
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-21869000
Quarters > 1 > cash Flow > capital Expenditures
1265500
Quarters > 1 > cash Flow > cash From Investing
-3407500
Quarters > 1 > cash Flow > cash From Financing
-1605000
Quarters > 1 > cash Flow > net Change In Cash
-26235500
Quarters > 1 > cash Flow > currency_symbol
EUR
Quarters > 1 > ratios > PE
-
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
-
Quarters > 1 > ratios > ROA
-
Quarters > 1 > ratios > FCF
-23134500
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
45
Quarters > 2 > quarter
2022-12-31
Quarters > 2 > income Statement > revenue
-
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
-
Quarters > 2 > income Statement > operating Income
-
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-
Quarters > 2 > income Statement > net Income
-
Quarters > 2 > income Statement > eps
-
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
-
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > income Statement > currency_symbol
EUR
Quarters > 2 > balance Sheet > cash
-
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
-
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
-
Quarters > 2 > balance Sheet > payables
-
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
-
Quarters > 2 > balance Sheet > equity
-
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
3887000
Quarters > 2 > cash Flow > depreciation
2712000
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-21869000
Quarters > 2 > cash Flow > capital Expenditures
1265500
Quarters > 2 > cash Flow > cash From Investing
-3407500
Quarters > 2 > cash Flow > cash From Financing
-1605000
Quarters > 2 > cash Flow > net Change In Cash
-26235500
Quarters > 2 > cash Flow > currency_symbol
EUR
Quarters > 2 > ratios > PE
-
Quarters > 2 > ratios > PB
-
Quarters > 2 > ratios > ROE
-
Quarters > 2 > ratios > ROA
-
Quarters > 2 > ratios > FCF
-23134500
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
45
Quarters > 3 > quarter
2022-09-30
Quarters > 3 > income Statement > revenue
-
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
-
Quarters > 3 > income Statement > operating Income
-
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-
Quarters > 3 > income Statement > net Income
-
Quarters > 3 > income Statement > eps
-
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
-
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
EUR
Quarters > 3 > balance Sheet > cash
-
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
-
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
-
Quarters > 3 > balance Sheet > payables
-
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
-
Quarters > 3 > balance Sheet > equity
-
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
0
Quarters > 3 > cash Flow > depreciation
2712000
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-21869000
Quarters > 3 > cash Flow > capital Expenditures
1265500
Quarters > 3 > cash Flow > cash From Investing
-3407500
Quarters > 3 > cash Flow > cash From Financing
-1605000
Quarters > 3 > cash Flow > net Change In Cash
-26235500
Quarters > 3 > cash Flow > currency_symbol
EUR
Quarters > 3 > ratios > PE
-
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
-
Quarters > 3 > ratios > ROA
-
Quarters > 3 > ratios > FCF
-23134500
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
45
Annuals > 0 > quarter
2018-12-31
Annuals > 0 > income Statement > revenue
257407000
Annuals > 0 > income Statement > cost Of Revenue
163251000
Annuals > 0 > income Statement > gross Profit
94156000
Annuals > 0 > income Statement > operating Expenses
-
Annuals > 0 > income Statement > operating Income
3346000
Annuals > 0 > income Statement > interest Expense
0
Annuals > 0 > income Statement > pretax Income
-894000
Annuals > 0 > income Statement > net Income
-4401000
Annuals > 0 > income Statement > eps
-
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
-
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
1.299886949461359
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > income Statement > currency_symbol
EUR
Annuals > 0 > balance Sheet > cash
-
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
54495000
Annuals > 0 > balance Sheet > inventories
131073000
Annuals > 0 > balance Sheet > total Current Assets
312971000
Annuals > 0 > balance Sheet > property Plant Equipment
34542000
Annuals > 0 > balance Sheet > total Assets
392129000
Annuals > 0 > balance Sheet > payables
-
Annuals > 0 > balance Sheet > short Term Debt
37470000
Annuals > 0 > balance Sheet > long Term Debt
30390000
Annuals > 0 > balance Sheet > total Liabilities
289038000
Annuals > 0 > balance Sheet > equity
103091000
Annuals > 0 > balance Sheet > currency_symbol
EUR
Annuals > 0 > cash Flow > net Income
-4401000
Annuals > 0 > cash Flow > depreciation
3311000
Annuals > 0 > cash Flow > change In Working Capital
-25604000
Annuals > 0 > cash Flow > cash From Operations
-18521000
Annuals > 0 > cash Flow > capital Expenditures
18741000
Annuals > 0 > cash Flow > cash From Investing
-18719000
Annuals > 0 > cash Flow > cash From Financing
49633000
Annuals > 0 > cash Flow > net Change In Cash
11422000
Annuals > 0 > cash Flow > currency_symbol
EUR
Annuals > 0 > ratios > PE
-
Annuals > 0 > ratios > PB
-
Annuals > 0 > ratios > ROE
-4.269043854458682
Annuals > 0 > ratios > ROA
-1.1223347418834109
Annuals > 0 > ratios > FCF
-37262000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-0.14475907803595084
Annuals > 0 > health Score
21
Annuals > 1 > quarter
2017-12-31
Annuals > 1 > income Statement > revenue
236485000
Annuals > 1 > income Statement > cost Of Revenue
169116000
Annuals > 1 > income Statement > gross Profit
67369000
Annuals > 1 > income Statement > operating Expenses
-
Annuals > 1 > income Statement > operating Income
-20805000
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
-23502000
Annuals > 1 > income Statement > net Income
-39201000
Annuals > 1 > income Statement > eps
-
Annuals > 1 > income Statement > dividends Per Share
8232000
Annuals > 1 > income Statement > shares Outstanding
-
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-8.797598156331269
Annuals > 1 > income Statement > total Other Income Expense Net
-
Annuals > 1 > income Statement > currency_symbol
EUR
Annuals > 1 > balance Sheet > cash
-
Annuals > 1 > balance Sheet > short Term Investments
35000
Annuals > 1 > balance Sheet > receivables
13252000
Annuals > 1 > balance Sheet > inventories
140288000
Annuals > 1 > balance Sheet > total Current Assets
257828000
Annuals > 1 > balance Sheet > property Plant Equipment
22686000
Annuals > 1 > balance Sheet > total Assets
332518000
Annuals > 1 > balance Sheet > payables
-
Annuals > 1 > balance Sheet > short Term Debt
15000000
Annuals > 1 > balance Sheet > long Term Debt
19286000
Annuals > 1 > balance Sheet > total Liabilities
223824000
Annuals > 1 > balance Sheet > equity
108694000
Annuals > 1 > balance Sheet > currency_symbol
EUR
Annuals > 1 > cash Flow > net Income
-39201000
Annuals > 1 > cash Flow > depreciation
3381000
Annuals > 1 > cash Flow > change In Working Capital
-27960000
Annuals > 1 > cash Flow > cash From Operations
-44641000
Annuals > 1 > cash Flow > capital Expenditures
15276000
Annuals > 1 > cash Flow > cash From Investing
-12871000
Annuals > 1 > cash Flow > cash From Financing
10193000
Annuals > 1 > cash Flow > net Change In Cash
-47291000
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
-
Annuals > 1 > ratios > PB
-
Annuals > 1 > ratios > ROE
-36.065468195116566
Annuals > 1 > ratios > ROA
-11.78913622721176
Annuals > 1 > ratios > FCF
-59917000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-0.25336490686512886
Annuals > 1 > health Score
22
Annuals > 2 > quarter
2016-12-31
Annuals > 2 > income Statement > revenue
328774000
Annuals > 2 > income Statement > cost Of Revenue
190213000
Annuals > 2 > income Statement > gross Profit
138561000
Annuals > 2 > income Statement > operating Expenses
-
Annuals > 2 > income Statement > operating Income
29207000
Annuals > 2 > income Statement > interest Expense
0
Annuals > 2 > income Statement > pretax Income
27899000
Annuals > 2 > income Statement > net Income
24440000
Annuals > 2 > income Statement > eps
-
Annuals > 2 > income Statement > dividends Per Share
40347000
Annuals > 2 > income Statement > shares Outstanding
-
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
8.883610017823793
Annuals > 2 > income Statement > total Other Income Expense Net
-
Annuals > 2 > income Statement > currency_symbol
EUR
Annuals > 2 > balance Sheet > cash
-
Annuals > 2 > balance Sheet > short Term Investments
20063000
Annuals > 2 > balance Sheet > receivables
2537000
Annuals > 2 > balance Sheet > inventories
132702000
Annuals > 2 > balance Sheet > total Current Assets
296757000
Annuals > 2 > balance Sheet > property Plant Equipment
16322000
Annuals > 2 > balance Sheet > total Assets
380617000
Annuals > 2 > balance Sheet > payables
-
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
27750000
Annuals > 2 > balance Sheet > total Liabilities
230226000
Annuals > 2 > balance Sheet > equity
150391000
Annuals > 2 > balance Sheet > currency_symbol
EUR
Annuals > 2 > cash Flow > net Income
24440000
Annuals > 2 > cash Flow > depreciation
2451000
Annuals > 2 > cash Flow > change In Working Capital
-48714000
Annuals > 2 > cash Flow > cash From Operations
-17018000
Annuals > 2 > cash Flow > capital Expenditures
12965000
Annuals > 2 > cash Flow > cash From Investing
48300000
Annuals > 2 > cash Flow > cash From Financing
-38781000
Annuals > 2 > cash Flow > net Change In Cash
-7151000
Annuals > 2 > cash Flow > currency_symbol
EUR
Annuals > 2 > ratios > PE
-
Annuals > 2 > ratios > PB
-
Annuals > 2 > ratios > ROE
16.25097246510762
Annuals > 2 > ratios > ROA
6.421153022592264
Annuals > 2 > ratios > FCF
-29983000
Annuals > 2 > ratios > Piotroski FScore
2
Annuals > 2 > ratios > fcf Percent
-0.09119638414229836
Annuals > 2 > health Score
45
Valuation > metrics > PE
1.3163
Valuation > final Score
70
Valuation > verdict
86.8% Undervalued
Profitability > final Score
50
Profitability > verdict
Weak
Risk > final Score
50
Risk > verdict
High
Liquidity > metrics > Current Ratio
7.349071101440896
Liquidity > metrics > Quick Ratio
4.46475358702433
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
50
Prev Profitabilities > 1
50
Prev Profitabilities > 2
50
Prev Risks > 0
50
Prev Risks > 1
50
Prev Risks > 2
50
Prev Liquidities > 0
100
Prev Liquidities > 1
50
Prev Liquidities > 2
50
Updated At
2026-01-20T22:53:03.535Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-27
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Ion Beam Applications SA designs, produces, and markets solutions for cancer diagnosis and treatments in Belgium, the United States, and internationally. It operates through Proton Therapy and Other Accelerators; and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production of positron emission tomography or SPECT radioisotopes, as well as a line of industrial accelerators for sterilization and ionization. The Dosimetry segment provides solutions and services that enhances efficiency and minimizes errors in radiation therapy and medical imaging quality assurance and calibration procedures. The company has strategic research and development partnership with SCK CEN, a Belgian nuclear research center focusing on the development of Actinium-225, a radioactive isotope for the treatment of cancer. It also develops ConformalFLASH, a novel technique using the proton Bragg peak. Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium.
Stock Price
€0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2023-06-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
* Institutions hold a combined 0.00% of the total shares of Ion Beam Applications S.A.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
—
EPS Actual
—
EPS Estimate
—
EPS Difference
—
Surprise Percent
undefined%
(Last Updated 2023-06-30)
(Last Updated 2023-06-30)
Revenue
€ 0
Cost Of Revenue
€ 0
Gross Profit
€ 0
Operating Expenses
€ 0
Operating Income
€ 0
Interest Expense
€ 0
Pretax Income
€ 0
Net Income
€ 0
Income Tax Expense
€ 0
EBITDA
€ 0
Total Other Income Expense Net
€ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2023-06-30)
Cash
€ 0
Short Term Investments
€ 0
Receivables
€ 0
Inventories
€ 0
Total Current Assets
€ 0
Property Plant Equipment
€ 0
Total Assets
€ 0
Payables
€ 0
Short Term Debt
€ 0
Long Term Debt
€ 0
Total Liabilities
€ 0
Equity
€ 0
(Last Updated 2023-06-30)
Net Income
€ 0
Depreciation
€ 0
Change In Working Capital
€ 0
Cash From Operations
€ 0
Capital Expenditures
€ 0
Cash From Investing
€ 0
Cash From Financing
€ 0
Net Change In Cash
€ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.